PERFORMANCE DATA

Test results

All of these third party tests were run using proprietary NPBI™ technology:

Woman Scientist giving command to the Rotary Evaporator machine at modern laboratory

SARS-CoV-2 (Covid-19)

TIME IN CHAMBER: 30 Minutes | RATE OF REDUCTION: 99.4%

This test was run using the iWave-C Air Ionization System P/N 4900-10 in a test designed to mimic ionization conditions like that of a commercial aircraft’s fuselage. Based on viral titrations, it was determined that at 10 minutes, 84.2% of the virus was inactivated. At 15 minutes, 92.6% of the virus was inactivated, and at 30 minutes, 99.4% of the virus was inactivated.

Human Coronavirus 229E

TIME IN CHAMBER: 60 Minutes | RATE OF REDUCTION: 90%

This test was run in a test chamber in a lab setting with the Nu-Calgon iWave-R Air Ionization System P/N 4900-20. A petri dish containing a pathogen is placed underneath a laboratory hood, then monitored to assess the pathogen’s reactivity to Needle Point Bipolar Ionization (NPBI) over time. This controlled environment allows for comparison across different types of pathogens.
NOTE: Human Coronavirus 229E is not SARS-CoV-2.

Please note that testing the reduction rate of SARS-Cov-2 and Human Coronavirus 229E with the iWave NPBI product is an evolving process and additional testing is anticipated to be conducted in the future. iWave products are not marketed as, nor cleared by, the FDA as a medical device.

UL Certification

iWave’s NPBI technology has been certified in accordance with UL 867 to produce no harmful levels of ozone.

iWave is UL and cUL approved.

Disclaimer

iWave uses multiple data points to formulate performance validation statements. iWave technology is used in a wide range of applications across diverse environmental conditions. Since locations will vary, clients should evaluate their individual application and environmental conditions when making an assessment regarding the technology’s potential benefits.

The use of this technology is not intended to take the place of reasonable precautions to prevent the transmission of disease. It is important to comply with all applicable public health laws and guidelines issued by federal, state, and local governments and health authorities as well as official guidance published by the Centers for Disease Control and Prevention (CDC), including but not limited to social distancing, hand hygiene, cough etiquette, and the use of face masks.